AFA
CL icon

Abacus FCF Advisors’s Colgate-Palmolive CL Stock Holding History

Abacus FCF Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.46M Sell
59,534
-73,371
-55% -$6.42M 1% 45
2026
Q1 		$11.3M Sell
132,905
-95,580
-42% -$8.52M 2.55% 12
2025
Q4 		$18.1M Buy
228,485
+5,310
+2% +$416K 2.36% 9
2025
Q3 		$17.8M Buy
223,175
+22,105
+11% +$1.89M 2.37% 12
2025
Q2 		$18.3M Buy
201,070
+38,907
+24% +$3.55M 2.56% 11
2025
Q1 		$15.2M Buy
162,163
+64,742
+66% +$5.8M 2.39% 12
2024
Q4 		$8.86M Buy
97,421
+39,530
+68% +$3.77M 1.17% 16
2024
Q3 		$6.01M Sell
57,891
-2,170
-4% -$221K 1.39% 17
2024
Q2 		$5.83M Sell
60,061
-2,478
-4% -$229K 1.45% 10
2024
Q1 		$5.63M Buy
62,539
+20,758
+50% +$1.76M 1.41% 16
2023
Q4 		$3.33M Buy
41,781
+19,381
+87% +$1.46M 0.97% 26
2023
Q3 		$1.59M Sell
22,400
-606
-3% -$45.3K 0.85% 30
2023
Q2 		$1.77M Buy
23,006
+2,531
+12% +$196K 0.89% 35
2023
Q1 		$1.54M Buy
20,475
+2,660
+15% +$198K 0.82% 38
2022
Q4 		$1.4M Buy
17,815
+3,372
+23% +$253K 0.92% 26
2022
Q3 		$1.01M Sell
14,443
-1,060
-7% -$83.1K 0.7% 46
2022
Q2 		$1.24M Sell
15,503
-8,556
-36% -$669K 0.76% 46
2022
Q1 		$1.82M Buy
24,059
+10,056
+72% +$797K 0.61% 53
2021
Q4 		$1.2M Hold
14,003
– – 0.59% 82
2021
Q3 		$1.07M Sell
14,003
-8,872
-39% -$704K 0.52% 99
2021
Q2 		$1.86M Sell
22,875
-1,694
-7% -$139K 0.95% 26
2021
Q1 		$1.95M Buy
24,569
+4,811
+24% +$377K 0.99% 29
2020
Q4 		$1.68M Sell
19,758
-1,845
-9% -$153K 0.98% 66
2020
Q3 		$1.72M Buy
21,603
+7,749
+56% +$591K 0.93% 70
2020
Q2 		$1.01M Sell
13,854
-615
-4% -$43.7K 0.96% 66
2020
Q1 		$944K Sell
14,469
-1,476
-9% -$104K 1.08% 55
2019
Q4 		$1.1M Sell
15,945
-369
-2% -$25.2K 0.87% 90
2019
Q3 		$1.2M Buy
16,314
+38
+0.2% +$2.76K 0.99% 68
2019
Q2 		$1.17M Buy
+16,276
New +$1.16M 0.96% 72

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Abacus FCF Advisors's CL Position: Q2 2026 in Review

Abacus FCF Advisors reduced its Colgate-Palmolive (CL) stake by 55% in Q2 2026, selling an estimated $6.42M and leaving 59,534 shares worth $5.46M. The position accounts for 1% of the portfolio, ranked #45.

Abacus FCF Advisors first reported a position in CL in Q2 2019 and has held it in 29 quarters since. The position peaked at $18.3M in Q2 2025. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Abacus FCF Advisors held 59,534 shares of Colgate-Palmolive worth $5.46M as of Q2 2026.
  • Abacus FCF Advisors sold 73,371 Colgate-Palmolive shares in Q2 2026, an estimated $6.42M.
  • Colgate-Palmolive made up 1% of Abacus FCF Advisors's portfolio in Q2 2026, its #45 holding.
  • Abacus FCF Advisors first reported a position in Colgate-Palmolive in Q2 2019 and has held it in 29 quarters since.
  • Abacus FCF Advisors's Colgate-Palmolive position peaked at $18.3M in Q2 2025.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Abacus FCF Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.